Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.

Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C.

Transpl Infect Dis. 2010 Feb;12(1):45-50. doi: 10.1111/j.1399-3062.2009.00455.x. Epub 2009 Sep 30.

2.

Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.

Trifilio S, Singhal S, Williams S, Frankfurt O, Gordon L, Evens A, Winter J, Tallman M, Pi J, Mehta J.

Bone Marrow Transplant. 2007 Sep;40(5):451-6. Epub 2007 Jun 25.

PMID:
17589527
4.

Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.

Siwek GT, Pfaller MA, Polgreen PM, Cobb S, Hoth P, Magalheas-Silverman M, Diekema DJ.

Diagn Microbiol Infect Dis. 2006 Jul;55(3):209-12. Epub 2006 Apr 19.

PMID:
16626917
5.

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.

Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.

Ann Intern Med. 2003 May 6;138(9):705-13.

PMID:
12729424
6.

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.

Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH.

Biol Blood Marrow Transplant. 2006 May;12(5):552-9.

7.

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients.

Cordonnier C, Maury S, Pautas C, Bastié JN, Chehata S, Castaigne S, Kuentz M, Bretagne S, Ribaud P.

Bone Marrow Transplant. 2004 May;33(9):943-8.

PMID:
15034546
8.

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.

Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846. Erratum in: Clin Infect Dis. 2009 Mar 1;48(5):690.

PMID:
19115967
9.

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.

Walsh TJ, Lutsar I, Driscoll T, Dupont B, Roden M, Ghahramani P, Hodges M, Groll AH, Perfect JR.

Pediatr Infect Dis J. 2002 Mar;21(3):240-8.

PMID:
12005089
10.

Antifungal agents in hematopoietic stem cell transplantation.

Parameswaran GI, Segal BH, Almyroudis NG.

Curr Pharm Des. 2008;14(20):2011-21. Review.

PMID:
18691111
11.

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.

Sinkó J, Csomor J, Nikolova R, Lueff S, Kriván G, Reményi P, Bátai A, Masszi T.

Transpl Infect Dis. 2008 Apr;10(2):106-9. Epub 2007 Jul 1.

PMID:
17605727
12.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K, Pigneux A, Cornely OA, Ullmann AJ, Bofarull RM, de la Cámara R, Weisser M, Liakopoulou E, Abecasis M, Heussel CP, Pineau M, Ljungman P, Einsele H; Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI) study group; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation.

Haematologica. 2010 Oct;95(10):1762-8. doi: 10.3324/haematol.2009.020073. Epub 2010 Jul 15.

13.

Voriconazole prophylaxis in lung transplant recipients.

Husain S, Paterson DL, Studer S, Pilewski J, Crespo M, Zaldonis D, Shutt K, Pakstis DL, Zeevi A, Johnson B, Kwak EJ, McCurry KR.

Am J Transplant. 2006 Dec;6(12):3008-16.

14.

[Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain].

Díaz Pedroche C, Cisneros JM, Lumbreras C, Aguado JM; Grupo Clinico Espanol de Estudio de Voriconazol.

Rev Esp Quimioter. 2005 Jun;18(2):149-58. Spanish.

15.

Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.

Morello E, Pagani L, Coser P, Cavattoni I, Cortelazzo S, Casini M, Billio A, Rossi G.

Bone Marrow Transplant. 2011 Jan;46(1):132-6. doi: 10.1038/bmt.2010.76. Epub 2010 Apr 12.

PMID:
20383205
16.

A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).

Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.

J Infect. 2007 Nov;55(5):445-9. Epub 2007 Sep 6.

PMID:
17822770
17.

Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.

Blennow O, Remberger M, Klingspor L, Omazic B, Fransson K, Ljungman P, Mattsson J, Ringdén O.

Bone Marrow Transplant. 2010 Dec;45(12):1710-8. doi: 10.1038/bmt.2010.38. Epub 2010 Mar 1.

PMID:
20190840
18.

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P.

J Clin Microbiol. 2005 Sep;43(9):4902-4. Review.

19.

Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nübling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E.

Clin Infect Dis. 2003 May 1;36(9):1122-31. Epub 2003 Apr 22.

PMID:
12715306
20.

Early fatal Rhizopus infection on voriconazole prophylaxis following allogeneic stem cell transplantation.

Ustun C, Farrow S, DeRemer D, Fain H, Jillella AP.

Bone Marrow Transplant. 2007 Jun;39(12):807-8. Epub 2007 Apr 16. No abstract available.

PMID:
17438583

Supplemental Content

Support Center